Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
2003 2
2004 5
2005 6
2006 3
2007 2
2008 3
2010 2
2012 1
2013 2
2015 2
2016 4
2017 5
2018 2
2019 4
2020 9
2021 5
2022 5
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.
Galiè N, Barberà JA, Frost AE, Ghofrani HA, Hoeper MM, McLaughlin VV, Peacock AJ, Simonneau G, Vachiery JL, Grünig E, Oudiz RJ, Vonk-Noordegraaf A, White RJ, Blair C, Gillies H, Miller KL, Harris JH, Langley J, Rubin LJ; AMBITION Investigators. Galiè N, et al. N Engl J Med. 2015 Aug 27;373(9):834-44. doi: 10.1056/NEJMoa1413687. N Engl J Med. 2015. PMID: 26308684 Free article. Clinical Trial.
Defining the clinical validity of genes reported to cause pulmonary arterial hypertension.
Welch CL, Aldred MA, Balachandar S, Dooijes D, Eichstaedt CA, Gräf S, Houweling AC, Machado RD, Pandya D, Prapa M, Shaukat M, Southgate L, Tenorio-Castano J; ClinGen PH VCEP; Chung WK; International Consortium for Genetic Studies in Pulmonary Arterial Hypertension (PAH-ICON) at the Pulmonary Vascular Research Institute (PVRI). Welch CL, et al. Genet Med. 2023 Nov;25(11):100925. doi: 10.1016/j.gim.2023.100925. Epub 2023 Jul 5. Genet Med. 2023. PMID: 37422716
Riociguat: Clinical research and evolving role in therapy.
Klinger JR, Chakinala MM, Langleben D, Rosenkranz S, Sitbon O. Klinger JR, et al. Among authors: chakinala mm. Br J Clin Pharmacol. 2021 Jul;87(7):2645-2662. doi: 10.1111/bcp.14676. Epub 2020 Dec 30. Br J Clin Pharmacol. 2021. PMID: 33242341 Free PMC article. Review.
World Health Organization group 5 pulmonary hypertension.
Lahm T, Chakinala MM. Lahm T, et al. Among authors: chakinala mm. Clin Chest Med. 2013 Dec;34(4):753-78. doi: 10.1016/j.ccm.2013.08.005. Epub 2013 Oct 18. Clin Chest Med. 2013. PMID: 24267303 Review.
Medical therapy for pulmonary arterial hypertension.
Driscoll JA, Chakinala MM. Driscoll JA, et al. Among authors: chakinala mm. Expert Opin Pharmacother. 2008 Jan;9(1):65-81. doi: 10.1517/14656566.9.1.65. Expert Opin Pharmacother. 2008. PMID: 18076339 Review.
Genotype-Phenotype Correlations in Children with HHT.
Kilian A, Latino GA, White AJ, Clark D, Chakinala MM, Ratjen F, McDonald J, Whitehead K, Gossage JR, Lin D, Henderson K, Pollak J, McWilliams JP, Kim H, Lawton MT, Faughnan ME; the Brain Vascular Malformation Consortium HHT Investigator Group. Kilian A, et al. Among authors: chakinala mm. J Clin Med. 2020 Aug 22;9(9):2714. doi: 10.3390/jcm9092714. J Clin Med. 2020. PMID: 32842615 Free PMC article.
Pneumonia in the solid organ transplant patient.
Chakinala MM, Trulock EP. Chakinala MM, et al. Clin Chest Med. 2005 Mar;26(1):113-21. doi: 10.1016/j.ccm.2004.10.010. Clin Chest Med. 2005. PMID: 15802173 Review.
Genetic counselling and testing in pulmonary arterial hypertension: a consensus statement on behalf of the International Consortium for Genetic Studies in PAH.
Eichstaedt CA, Belge C, Chung WK, Gräf S, Grünig E, Montani D, Quarck R, Tenorio-Castano JA, Soubrier F, Trembath RC, Morrell NW; for PAH-ICON associated with the PVRI. Eichstaedt CA, et al. Eur Respir J. 2023 Feb 23;61(2):2201471. doi: 10.1183/13993003.01471-2022. Print 2023 Feb. Eur Respir J. 2023. PMID: 36302552 Free PMC article.
65 results